Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$200,630,776
+$13,610,261 QoQ
Shares Held
1,561,329
+0.4% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#136
of 3,789 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 90%
Shared 0%
None 9%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Derivatives in MRK
reported options exposure · as of Jun 30, 2023CallValue
$0
CallShares
0
PutValue
$55,457,703
PutShares
480,611
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026US BANCORP \DE\ holds $3,650,078,543 across 17 Drug Manufacturers - General names. MRK ranks #5 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,354,723 | $1,624,895,541 | |
| 2 | JNJ |
Johnson & Johnson
|
2,500,270 | $634,993,570 | |
| 3 | ABBV |
AbbVie Inc.
|
2,295,401 | $577,614,705 | |
| 4 | AMGN |
Amgen Inc
|
664,266 | $240,544,002 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
1,561,329 | $200,630,776 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
852,290 | $107,678,317 | |
| 7 | PFE |
Pfizer Inc
|
3,685,691 | $88,751,436 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,291,483 | $74,415,248 |
All Filings in MRK
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $200,630,776 | 1,561,329 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $187,020,515 | 1,554,747 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $166,397,216 | 1,580,821 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $137,078,418 | 1,633,247 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $134,746,941 | 1,702,210 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $163,136,463 | 1,817,474 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $190,225,355 | 1,912,197 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $223,233,633 | 1,965,777 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $249,058,733 | 2,011,783 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $267,238,597 | 2,025,302 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $220,949,959 | 2,026,692 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $214,233,903 | 2,080,951 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $55,457,703 | 480,611 | Put | Other | 2023-08-10 | |
| 2023-06-30 | $193,718,461 | 1,678,815 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $235,438,621 | 2,212,977 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $247,079,323 | 2,226,943 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $154,037,331 | 1,788,636 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $172,161,324 | 1,888,355 | Shares | Defined | 2022-08-01 | |
| 2022-03-31 | $153,990,864 | 1,876,793 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $146,436,659 | 1,910,708 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $142,955,359 | 1,903,280 | Shares | Other | 2021-11-10 | |
| 2021-06-30 | $148,436,098 | 1,908,655 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $148,019,431 | 1,920,085 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $160,362,364 | 1,960,421 | Shares | Defined | 2021-02-04 | |
| 2020-09-30 | $165,810,323 | 1,998,918 | Shares | Defined | 2020-11-10 | |
| 2020-09-30 | $31,686 | 382 | Put | Other | 2020-11-10 | |
| 2020-06-30 | $29,540 | 382 | Put | Other | 2020-08-07 | |
| 2020-06-30 | $155,966,866 | 2,016,899 | Shares | Defined | 2020-08-07 | |
| 2020-03-31 | $25,697 | 334 | Put | Other | 2020-05-13 | |
| 2020-03-31 | $156,286,848 | 2,031,283 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||